Skip to content
OpenCapital
Get started

Annovis Bio ANVS Q1 2026 earnings

Reported May 15, 2026 · Before market open

Diluted EPS-$0.63Miss by $0.24
EPS estimate-$0.40

Next report

Aug 11, 2026 (in a month)
EPS estimate-$0.44

Versus estimates

Diluted EPS

Q1 2026-$0.63Miss by $0.24
Q4 2025-$0.39Miss by $0.08Q3 2025-$0.37Miss by $0.01Q2 2025-$0.32Beat by $0.04Q1 2025-$0.32Beat by $0.15Q4 2024-$0.43Miss by $0.05

Ask the moment Annovis Bio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Annovis Bio report Q1 2026 earnings?
Annovis Bio (ANVS) reported Q1 2026 earnings on May 15, 2026 before market open.
What were Annovis Bio's Q1 2026 revenue and EPS?
Annovis Bio reported diluted EPS of $-0.63 for Q1 2026.
Did Annovis Bio beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.40 by $0.23.
How did Annovis Bio's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 96.9% from $-0.32.
Where can I find Annovis Bio's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-062451) and the 10-Q periodic report (0001104659-26-062626) directly on SEC EDGAR. The filing index links above go to sec.gov.